Comparison

B4GalT1 Antibody (C-term) Blocking Peptide

Item no. ABC-BP8892b
Manufacturer Abcepta
Amount 500 ug
Category
Type Peptides
Format Lyophilized
Specific against other
Citations Mengle-Gaw,L., et.al., Biochem. Biophys. Res. Commun. 176 (3), 1269-1276 (1991)
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias Beta-1,4-galactosyltransferase 1,Beta-1,4-GalTase 1,Beta4Gal-T1,b4Gal-T1,241-,UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1,UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1,Lactose synthase A protein,N-acetyllactosamine synthase,Nal synthase,Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase,Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase,241-,Processed beta-1,4-galactosyltransferase 1,B4GALT1,GGTB2
Similar products B4GALT1, Beta-1, UDP-Gal:beta-GlcNAc beta-1, UDP-galactose:beta-N-acetylglucosamine beta-1, N-acetyllactosamine synthase, Nal synthase, GGTB2, 4-galactosyltransferase 1, 4-galactosyltransferase, 241-, Beta4Gal-T1, 4-GalTase 1, b4Gal-T1, Beta-N-acetylglucosaminylglycopeptide beta-1, Lactose synthase A protein, Processed beta-1, Beta-N-acetylglucosaminyl-glycolipid beta-1
Available
Manufacturer - Category
Peptides; Blocking Peptides
Manufacturer - Targets
The synthetic peptide sequence used to generate the antibody AP8892b was selected from the C-term region of human B4GalT1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Bio Background
B4GalT1 is an enzyme that participates both in glycoconjugate and lactose biosynthesis. For the first activity, the enzyme adds galactose to N-acetylglucosamine residues that are either monosaccharides or the nonreducing ends of glycoprotein carbohydrate chains. The second activity is restricted to lactating mammary tissues where the enzyme forms a heterodimer with alpha-lactalbumin to catalyze UDP-galactose + D-glucose <=> UDP + lactose. The two enzymatic forms result from alternate transcription initiation sites and post-translational processing.
Gene Name
B4GALT1
Subtitle
Synthetic peptide
Formulation
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close